The efficacy of the antiviral R 61837 in experimental colds in three previously reported volunteer trials and one new trial is reviewed here. It was dissolved in a new vehicle, hydroxy-β-cyclodextrin, and used as a nasal spray. A substantial reduction in illness occurred when given prophylactically and during the incubation period but not when used therapeutically.
References
1.
Al-NakibW., and TyrrellD.A.J. (1987) A ‘new’ generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions. Antiviral Res8: 179–188.
2.
Al-NakibW.HigginsP.G.WillmanJ.TyrrellD.A.J.SwallowD.L.HurstB.C., and RushtonA. (1986) Prevention and treatment of experimental influenza with a new antiviral ICI 130685. J Antimicrob Chemother18: 119–129.
3.
Al-NakibW.HigginsP.G.BarrowI.TyrrellD.A.J.Lennox-SmithI., and IshitsukaH. (1987a) Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers. J Antimicrob Chemother20: 887–892.
4.
Al-NakibW.WillmanJ.HigginsP.G.TyrrellD.A.J.ShepherdW.M., and FreestoneD.S. (1987b) Failure of intranasally administrered 4′, 6 dichloroflavan to protect against rhinovirus infection in man. Arch Virol92: 255–260.
5.
Al-NakibW.HigginsP.G.BarrowG.I.TyrrellD.A.J.AndriesK.Vanden BusscheG.TaylorN., and JanssenP.A.J. (1989) Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R 61837). Antimicrob Agents Chemother33: 522–525.
6.
AndriesK.B.DewindtM.BrabanderR.StokbroekxR., and JanssenP.A.J. (1988) In vitro activity of R 61837, a new antirhinovirus compound. Arch Virol101: 155–167.
7.
BeareA.S., and ReedS.E. (1977) The study of antiviral compounds in volunteers. In: Chemoprophylaxis and Virus Infections of the Respiratory Tract (ed. OxfordJ.S.). Vol. 2, pp. 27–35. CRC Press, Cleveland.
8.
DeardenC.Al-NakibW.AndriesK.WoestenborghsR., and TyrrellD.A.J. (1989) Drug resistant rhinoviruses from the nose of experimentally treated volunteers. Arch Virol109: 71–81.
9.
HaydenF.G., and GwaltneyJ.M. (1984) Intranasal interferon-α2 treatment of experimental rhinoviral colds. J Infect Dis150: 174–180.
10.
SmithT.J.KremerM.J.LuoM.VriendG.ArnoldF.KamarG.RossmannM.G.McKinlayM.A.DianaG.D., and OttoM.J. (1986) The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science233: 1286–1293.
11.
SperberS.J., and HaydenF.G. (1988) Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother32: 409–419.
